LR is a 36 y/o, 61kg female with a history of asthma and HTN seen in your clinic. You see that she is taking Nordette 28, a combined oral contraceptive containing 30mcg of estradiol and 0.15mg of levonorgestrel. She is generally pleased with her contraceptive which she has been taking successfully for years. What modification is advised based on the information you have about LR?

Testosterone is the primary androgen hormone responsible for male sexual development, secondary sexual characteristics, and anabolic effects on muscle and bone. Beyond its direct androgenic activity, testosterone is also metabolized into other biologically active hormones that influence both masculinizing and estrogenic effects in the body. These metabolic conversions occur through enzymatic pathways involving aromatase and 5-alpha reductase. Understanding these pathways helps explain the diverse physiologic effects of testosterone in both males and females.

Rationale:
A. Testosterone is converted into Dihydrotestosterone (DHT) via the enzyme 5-alpha reductase, which produces a more potent androgen responsible for effects such as prostate growth, body hair development, and male pattern baldness. It is also converted into Estradiol through the enzyme aromatase, which plays a role in bone health, libido regulation, and feedback control of gonadotropin release. These two metabolites represent the primary active hormonal derivatives of testosterone.

B. Estradiol and progesterone are not both direct metabolic products of testosterone. While estradiol can be derived from testosterone via aromatization, progesterone is a separate steroid hormone primarily produced in the ovaries and adrenal glands. This pairing does not accurately reflect testosterone metabolism.

C. Dihydrotestosterone is correctly derived from testosterone, but progesterone is not a downstream metabolite of testosterone. Progesterone is an upstream precursor in steroid hormone synthesis pathways rather than a direct breakdown product of testosterone. This makes the combination biologically inaccurate.

D. Ethinyl estradiol is a synthetic estrogen used in oral contraceptives and is not a natural metabolite of testosterone. Androstenedione is actually a precursor in androgen and estrogen synthesis pathways rather than a breakdown product of testosterone. Therefore, this option is incorrect.

Selective serotonin reuptake inhibitors (SSRIs) are commonly used as first-line treatment for major depressive disorder because they improve mood by increasing serotonin availability in the brain. Patient education is important to improve adherence, especially during the first few weeks when side effects may occur before full therapeutic benefit is noticed. Many patients discontinue therapy early if they are not prepared for these temporary effects. Proper counseling helps improve treatment success and reduces unnecessary medication discontinuation.

Rationale:
A. Rising slowly from a lying or sitting position is more commonly emphasized with tricyclic antidepressants or antihypertensive medications that frequently cause orthostatic hypotension. Although SSRIs may occasionally cause dizziness, orthostatic hypotension is not a major expected adverse effect of Citalopram. This is not the primary counseling point that should be emphasized for routine SSRI initiation.

B. Citalopram should not be titrated rapidly every 2 days because antidepressants require gradual dose adjustments and time to assess response and tolerance. Rapid titration increases the risk of adverse effects such as serotonin syndrome, QT prolongation, and patient intolerance. Clinical improvement also takes several weeks, so aggressive dose escalation is inappropriate.

C. Minor side effects such as nausea, mild somnolence, headache, and insomnia are common during the early phase of SSRI treatment and are usually temporary. These symptoms often improve within 1 to 2 weeks as the body adjusts to the medication. Educating the patient about this helps reduce anxiety, improves adherence, and prevents premature discontinuation before therapeutic benefits are achieved.

D. Abrupt discontinuation of SSRIs can lead to discontinuation syndrome, which may include dizziness, irritability, flu-like symptoms, and sensory disturbances. Although some SSRIs with longer half-lives have lower risk, citalopram still requires gradual tapering rather than sudden cessation. Patients should always be instructed not to stop the medication suddenly without provider guidance.